share_log

Chewy | 10-Q: Q2 2025 Earnings Report

SEC ·  Aug 28, 2024 19:32

Summary by Futu AI

Chewy reported robust financial results for Q2 fiscal 2024, with net sales increasing 2.6% to $2.86 billion compared to the same period last year. The company's net income surged to $299.1 million, significantly up from $20.2 million in Q2 2023, while gross profit rose 7% to $843.8 million with margins expanding by 120 basis points to 29.5%.The company demonstrated strong operational efficiency with selling, general and administrative expenses remaining relatively flat at $621.3 million. Autoship customer sales, a key metric for recurring revenue, grew 5.8% to $2.24 billion, representing 78.4% of total net sales. Net sales per active customer increased 6.2% to $565, though active customers slightly decreased by 1.8% to 20 million.Looking ahead, Chewy maintains a strong liquidity position with $694.5 million in cash and cash equivalents. The company initiated a $500 million share repurchase program and completed a significant stock buyback of 17.55 million shares at $28.49 per share. Management remains focused on expanding healthcare and specialty businesses while driving operational efficiencies across the fulfillment network.
Chewy reported robust financial results for Q2 fiscal 2024, with net sales increasing 2.6% to $2.86 billion compared to the same period last year. The company's net income surged to $299.1 million, significantly up from $20.2 million in Q2 2023, while gross profit rose 7% to $843.8 million with margins expanding by 120 basis points to 29.5%.The company demonstrated strong operational efficiency with selling, general and administrative expenses remaining relatively flat at $621.3 million. Autoship customer sales, a key metric for recurring revenue, grew 5.8% to $2.24 billion, representing 78.4% of total net sales. Net sales per active customer increased 6.2% to $565, though active customers slightly decreased by 1.8% to 20 million.Looking ahead, Chewy maintains a strong liquidity position with $694.5 million in cash and cash equivalents. The company initiated a $500 million share repurchase program and completed a significant stock buyback of 17.55 million shares at $28.49 per share. Management remains focused on expanding healthcare and specialty businesses while driving operational efficiencies across the fulfillment network.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.